Latest Regulation News

Ausmon Resources Limited has launched a Share Purchase Plan aiming to raise up to $540,000 by issuing shares at a discounted price, supporting its exploration and operational funding needs.

Polymetals Resources Ltd has opened a Share Purchase Plan allowing eligible shareholders to invest up to $30,000 each at $0.80 per share, aiming to raise $3.2 million to bolster its balance sheet and fund exploration.

Judo Capital Holdings Limited has released its Basel III Pillar 3 report for the half year ended December 31, 2024, revealing a robust capital position and detailed credit risk exposures that exceed regulatory transparency requirements.

The Star Entertainment Group has received a $650 million debt refinancing proposal from Oaktree Capital Management, offering a potential boost to its liquidity but shadowed by significant conditions and uncertainty.

Carbonxt Group Limited has initiated a $2 million Share Purchase Plan following successful capital raises, aiming to bolster its Kentucky activated carbon facility as it nears commercial production.

Neurizon Therapeutics received FDA guidance on its IND application for NUZ-001, with a single request for additional animal exposure data but no safety concerns flagged. The company is actively addressing the FDA’s request while evaluating impacts on its ALS trial timeline.

Aurizon Holdings reported a 3% revenue increase in its half-year FY2025 results, driven by higher coal volumes, but underlying NPAT fell 14% due to rising costs and customer mix effects. The company’s strong free cash flow supports an expanded $300 million buy-back program.

Aurizon Holdings posted a 3% revenue increase to $2.02 billion for 1HFY2025 but saw EBITDA dip 4% to $814 million, reflecting operational headwinds across key segments. The company declared a 9.2 cents per share interim dividend, signaling cautious optimism despite margin pressures.

Bendigo and Adelaide Bank has released its Basel III Pillar 3 disclosures for the year ended December 31, 2024, revealing solid capital adequacy and liquidity positions under APRA regulations. The bank maintains robust buffers amid lending growth and evolving market conditions.

Sprintex has completed commissioning of its compressor systems with Mest Water and is poised to receive a €3.8 million purchase order, marking a pivotal step in expanding its environmental technology footprint across the EU.

Entyr Limited has extended the closing date for its capital raising offers to 3 March 2025, providing investors additional time to participate in new share and option subscriptions.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.